Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China
· Delayed Price · Currency is CNY 4.130
-0.010 (-0.24%)
Apr 30, 2026, 3:04 PM CST
SHE:300194 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 62.35 | 76.49 | 279.84 | 231.87 | 204.61 | -296.91 | Upgrade
|
| Depreciation & Amortization | 205.27 | 205.27 | 198.26 | 209.07 | 184.43 | 174.29 | Upgrade
|
| Other Amortization | 1.26 | 1.26 | 0.96 | 0.72 | 0.97 | 0.7 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.27 | -0.27 | -0.01 | -220.65 | -4.85 | -0.31 | Upgrade
|
| Asset Writedown & Restructuring Costs | 154.1 | 154.1 | 37.77 | 228.06 | 25.41 | 827.23 | Upgrade
|
| Loss (Gain) From Sale of Investments | -138.55 | -138.55 | -77.37 | -77.8 | -62.16 | -52.47 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 3.96 | -2.43 | 3.68 | 4.27 | Upgrade
|
| Other Operating Activities | 99.36 | 27.68 | 54.05 | 44.66 | 46.76 | -286.2 | Upgrade
|
| Change in Accounts Receivable | 77.95 | 77.95 | 46.84 | 71.85 | -78.5 | -68.26 | Upgrade
|
| Change in Inventory | 215.3 | 215.3 | -182.31 | 9.2 | -120.85 | -65.3 | Upgrade
|
| Change in Accounts Payable | -285.65 | -285.65 | -72.15 | -193.15 | 159.88 | 24.98 | Upgrade
|
| Change in Other Net Operating Assets | 0.73 | 0.73 | 10.07 | 4.8 | 4.4 | - | Upgrade
|
| Operating Cash Flow | 369.87 | 312.32 | 303.59 | 328.98 | 339.5 | 257.13 | Upgrade
|
| Operating Cash Flow Growth | 110.49% | 2.88% | -7.72% | -3.10% | 32.04% | 58.18% | Upgrade
|
| Capital Expenditures | -89.26 | -108.43 | -241.79 | -215.68 | -383.1 | -413.03 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.48 | 5.91 | 0.3 | 122.67 | 4.28 | 31.49 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -1 | Upgrade
|
| Divestitures | - | - | -4.63 | - | -0.06 | - | Upgrade
|
| Investment in Securities | -140 | -120 | -54.81 | -1.25 | -71.43 | 32.38 | Upgrade
|
| Other Investing Activities | -19.25 | -0.03 | 36.1 | 0.64 | 10.31 | 0.94 | Upgrade
|
| Investing Cash Flow | -248.03 | -222.56 | -264.83 | -93.62 | -440.01 | -349.24 | Upgrade
|
| Short-Term Debt Issued | - | - | 83.04 | - | 49.28 | - | Upgrade
|
| Long-Term Debt Issued | - | 1,052 | 485.09 | 848.08 | 588.56 | 964.75 | Upgrade
|
| Total Debt Issued | 427.1 | 1,052 | 568.13 | 848.08 | 637.84 | 964.75 | Upgrade
|
| Short-Term Debt Repaid | - | - | -37 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -971.15 | -666.25 | -706.06 | -802.42 | -683 | Upgrade
|
| Total Debt Repaid | -660.13 | -971.15 | -703.25 | -706.06 | -802.42 | -683 | Upgrade
|
| Net Debt Issued (Repaid) | -233.03 | 80.65 | -135.12 | 142.02 | -164.58 | 281.75 | Upgrade
|
| Common Dividends Paid | -103.8 | -104.99 | -84.22 | -93.98 | -28.09 | -84.11 | Upgrade
|
| Other Financing Activities | -12.64 | 14.39 | -8.59 | -1.78 | 20.99 | 13.77 | Upgrade
|
| Financing Cash Flow | -349.47 | -9.96 | -227.93 | 46.25 | -171.68 | 211.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.28 | 0.36 | 0.91 | 0.88 | 2.91 | -2.17 | Upgrade
|
| Net Cash Flow | -227.92 | 80.17 | -188.26 | 282.49 | -269.27 | 117.13 | Upgrade
|
| Free Cash Flow | 280.61 | 203.89 | 61.8 | 113.3 | -43.6 | -155.91 | Upgrade
|
| Free Cash Flow Growth | - | 229.94% | -45.46% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 16.72% | 11.73% | 2.58% | 4.28% | -1.80% | -6.35% | Upgrade
|
| Free Cash Flow Per Share | 0.22 | 0.16 | 0.05 | 0.09 | -0.04 | -0.13 | Upgrade
|
| Cash Income Tax Paid | 144.62 | 136.58 | 202.61 | 198.28 | 155.41 | 190.43 | Upgrade
|
| Levered Free Cash Flow | 246.65 | 167.83 | -37.48 | 98.2 | -60.74 | -139.3 | Upgrade
|
| Unlevered Free Cash Flow | 246.65 | 167.83 | -22.89 | 116.68 | -43.91 | -126.52 | Upgrade
|
| Change in Working Capital | -13.65 | -13.65 | -193.86 | -84.51 | -59.35 | -113.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.